FinTechFunding

Mayne Pharma: Appoints former AstraZeneca leader as new CEO

Mayne Pharma Appoints former AstraZeneca leader as new CEO

  • Mayne Pharma (MYX) appoints Shawn Patrick O’Brien as its new CEO and Managing Director
  • Following the retirement of Scott Richards, announced last month, Mr O’Brien will take the reigns on October 1
  • MYX says with over 35 years of experience in the global pharmaceutical industry, including 17 years at AstraZeneca, the new CEO is an “ideal choice” to lead the company
  • The company says Mr O’Brien has “a proven ability” to turn around organisations, lead large and diverse teams, and deliver growth within both public and private companies
  • MYX shares are up 4.9 per cent trading at 27 cents at 1:36 pm AEST
Previous article
Checkmate: Lands $5m seed funding
Next article
Spacetalk: Officially launches JumpySIM in Australia
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Swedish Court Delays Judgment in Klarna’s Antitrust Case Against Google

The court's decision is crucial for Klarna's operations in the competitive market.Highlights: Swedish court delays decision on Klarna's...
FinTech

Morgan Stanley Launches Bitcoin ETF, Expanding Crypto Offerings

The investment firm broadens its reach into the cryptocurrency market.Highlights: Morgan Stanley launches a Bitcoin ETF to enhance...
FinTech

HSBC Strengthens Position with Hong Kong Stablecoin Issuer License

The banking giant aims to support digital asset initiatives in the region.Highlights: HSBC receives a stablecoin issuer license...
FinTech

US Treasury Secretary Warns Banks About Anthropic’s New AI Model

Treasury Secretary highlights risks AI poses to financial stability.Highlights: US Treasury Secretary warns banks about the risks of...